SMRTR AIApr 16, 2026Ars Technica

OpenAI starts offering a biology-tuned LLM

SMRTR summary

OpenAI released GPT-Rosalind, a biology-focused AI model that gives more cautious responses about drug targets and biological processes. Access is limited to approved US entities due to safety concerns about potential misuse.

SMRTR provides this summary for quick context. The original article belongs to Ars Technica.

Read the original article
SMRTR AI

Get the next batch of curated summaries in your inbox.

This archive is built from SMRTR newsletter summaries. Subscribe for hand-picked stories without the extra noise.